An orally bioavailable agent that is selective towards adrenal cortex cells with potential antitumor activity. Upon administration, ATR-101 selectively kills adrenal and adrenal cancer cells, through an unknown mechanism.
Learn more about ATR-101
Latest research - ATR-101
This WikiMD article ATR-101 is a stub. If you are familiar with the topic ATR-101, you can help us. Paid editors welcome!
ATR-101 is part of WikiMD's free ^articles!
^ATR-101 (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.